Savara Pharmaceuticals
SVRA
#6474
Rank
โ‚ฌ0.55 B
Marketcap
3,22ย โ‚ฌ
Share price
3.70%
Change (1 day)
-3.27%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -โ‚ฌ69.84 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ52.49 Million a decrease over its 2022 earnings that were of -โ‚ฌ36.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ69.84 Million33.06%
2023 -โ‚ฌ52.49 Million43.38%
2022 -โ‚ฌ36.61 Million-11.31%
2021 -โ‚ฌ41.28 Million-13.3%
2020 -โ‚ฌ47.61 Million-36.53%
2019 -โ‚ฌ75.01 Million13.76%
2018 -โ‚ฌ65.94 Million105.54%
2017 -โ‚ฌ32.08 Million34.11%
2016 -โ‚ฌ23.92 Million-37.43%
2015 -โ‚ฌ38.23 Million38.81%
2014 -โ‚ฌ27.54 Million33.62%
2013 -โ‚ฌ20.62 Million38.49%
2012 -โ‚ฌ14.89 Million24.59%
2011 -โ‚ฌ11.95 Million-36.5%
2010 -โ‚ฌ18.82 Million-3.14%
2009 -โ‚ฌ19.43 Million-23.28%
2008 -โ‚ฌ25.32 Million8.52%
2007 -โ‚ฌ23.33 Million-34.14%
2006 -โ‚ฌ35.42 Million184.43%
2005 -โ‚ฌ12.46 Million90.75%
2004 -โ‚ฌ6.53 Million190.35%
2003 -โ‚ฌ2.25 Million11.64%
2002 -โ‚ฌ2.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ17.43 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.24 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA